insights_auto
Nega 4519 oshdi 2,51%?
Batafsil oʻrganishchevron_right
4519:TYO
Chugai Pharmaceutical Co Ltd
6 170,00 JP¥
arrow_upward
+2,51%(+151,00) 1K
13-okt, 15:30:00 (GMT+9) · JPY
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto4519 tikeri uchun statistika yaratilmoqda...
Ochish
6 100 JP¥
Yuqori
6 170 JP¥
Past
6 078 JP¥
Bozor kapitali
10,36 trln
Oʻrtacha hajm
2,99 mln
Hajmi
2,64 mln
Dividend
2,24%
Choraklik dividendlar
34 JP¥
Eks-dividend sanasi
29-iyn, 2026
P/E koeffitsiyenti
21,54
52 haftalik eng yuqori
10 700 JP¥
52 haftalik eng past
5 974 JP¥
Aksiya boʻyicha daromad
286 JP¥
Muomaladagi aksiyalar
547,19 mln
Xodimlar soni
5 ming
Ochish
6 100 JP¥
Yuqori
6 170 JP¥
Past
6 078 JP¥
Bozor kapitali
10,36 trln
Oʻrtacha hajm
2,99 mln
Hajmi
2,64 mln
Dividend
2,24%
Choraklik dividendlar
34 JP¥
Eks-dividend sanasi
29-iyn, 2026
P/E koeffitsiyenti
21,54
52 haftalik eng yuqori
10 700 JP¥
52 haftalik eng past
5 974 JP¥
Aksiya boʻyicha daromad
286 JP¥
Muomaladagi aksiyalar
547,19 mln
Xodimlar soni
5 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
13 soat oldin
Chugai reports Week 52 vamikibart data for Chugai Pharmaceutical stock
ad-hoc-news.de
·
1 kun oldin
Chugai Pharmaceutical stock after-hours at EUR 33.94
ad-hoc-news.de
·
1 kun oldin
Chugai Pharmaceutical stock at EUR 34.02, market value JPY 9.9 trillion
ad-hoc-news.de
·
1 kun oldin
Citi keeps Buy rating for Chugai Pharmaceutical stock at JPY 11,100.00
Profil
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
Chugai Pharmaceutical Co Ltd haqida
CEOOsamu Okuda
Xodimlar soni5,1 ming
Asos solingan10-mar, 1925
Bosh ofislar-
Sektor-
Veb-saytchugai-pharm.co.jp